Nadia Rodriguez’s Post

🎉 Exciting news from AusperBio! AusperBio is proud to announce the completion of our $73M Series B financing, led by HanKang Capital with support from Sherpa Capital, CDH Investments, and others. This funding will accelerate the development of our lead program, AHB-137, and support global clinical trials as we work to advance innovative therapies for chronic hepatitis B (CHB). Thank you to our investors for their confidence in our mission and to our team for their dedication. Together, we’re driving impactful change in CHB care. 📖 Read more here: https://lnkd.in/gawj-JWc #Biotech #HepatitisB #CHBTreatment #FunctionalCure #SeriesBFunding #HealthcareInnovation #GlobalHealth

🌟 Giuliana Villari, one of the key figures in the Business Matching of Network PerfeTTO, gave an interview for the BioFIT Event. Check it out below 👇 #PerfeTTONetwork #BioFit2024 #Innovation #Networking #Biotech #BusinessMatching #Interview

New tips and protocol available for #invitro #hepatocyte suspension incubations (with video)! Cryopreserved primary #hepatocytes are a valuable tool for predicting the intrinsic clearance of compounds, reactive &/or toxic metabolite formation and the number of #metabolites formed, inhibition of endogenous metabolic enzymes, and which #preclinical model might be the most representative for #toxicology studies. Considering the importance of these assays, we compiled a list of useful tips and procedures to help you increase the quality and reproducibility of your data. Read the tips, watch the video and download the protocol: https://lnkd.in/gs7Sfx4T #ADME #DMPK #DrugMetabolism #DrugInteractions

BioKryo: A European biobanking network built on innovation and excellence! Since 2010, BioKryo has been shaping the future of #biobanking with innovative and sustainable solutions. As part of a strong European #network, we ensure that every site operates with the highest standards of certifications and accreditations ✅    🚀 Here’s some key milestones of our journey : → 2010 : BioKryo opens its doors, setting the foundation for a trusted biobanking partner. → 2018 : We integrate Air Liquide Healthcare’s biobanking network → 2022 : We launch a unified brand design for the biobank network   Today, each BioKryo’s facilities obtains the highest certifications and accreditations, guaranteeing the same quality and trustworthiness for our clients!   BioKryo aims to contribute to a world of sustainable scientific and #healthcare services by providing the scientific community with highly secure biobanking solutions.   👉 Reach out to us to learn more about us: https://lnkd.in/eb6_iT69   #cryopreservation #biobanking #samplesafety #riskmanagement #traceability

Exciting News! After a long considerations, Finally we are "Authorized Distributor" for ProteinSimple, a Bio-Techne brand. We have lunched that great big news at BIOEXPO "Yaşam Bilimleri" Fuarları Simon A. Sumer has shared his invaluable experienced on the systems with our sales team, subdealers and end user customers. This post mainly includes the features one of the SimpleWestern system which is called JESS automated western blot system. JESS is unique, easy to use fully automated western blot device. Jess needs only 3 µL samples, 10 minutes for preparing plates and cartiges Thats all! If You think that it is quite tough to detect proteins at the EV's research. See the detailed how to use instructions below. Advance Your Protein Extracellular Vesicle Analysis with Bio-Techne´s Simple Western Systems The enhanced #sensitivity, #quantitation and #reproducibility makes #SimpleWestern Technology the ideal solution for extracellular vesicle (EV)-based research and development (R&D). Simple Western Technology simplifies and automates the traditional western blotting process by integrating it into a fully automated capillary system. Simple Western Systems supports you from discovery to development and beyond. The Simple Western Advantages for #EV R&D - Low Sample Volume: Save precious EV sample preps! Use as little as 3 µL   of sample per well - Highly Sensitive Multiplex: Industry-leading multi-channel immunodetection sensitivity plus simultaneous Total Protein assays - Complex Sample Types: EV samples, cell lysates, and liquid biopsies        (urine, serum, plasma and more) - Fast and Fully Automated: Fully quantitative and reproducible results in just 3 hours Download the comprehensive flyer here: https://lnkd.in/evu6Fw-w

It’s critical that the correct species are selected for #preclinical #toxicology studies to accurately evaluate the safety of an NCE before it progresses to human clinical trials. Understanding the metabolic pathways of the NCE in different species #invitro increases the likelihood that the findings will be applicable to human safety. Learn more about in vitro cross-species comparison: https://hubs.ly/Q02Gy0190 #DrugMetabolism #ADME #DMPK

🚀 How BioMan4R2 is Powering Innovation at JAFRAL Biosolutions! ⏩ Check out our #17 BioMan4R2 Success Story! 🏅 JAFRAL Biosolutions -one of the awarded companies within the 𝘽𝙐𝙎𝙄𝙉𝙀𝙎𝙎 𝙏𝙍𝘼𝙉𝙎𝙁𝙊𝙍𝙈𝘼𝙏𝙄𝙊𝙉 𝙁𝙄𝙉𝘼𝙉𝘾𝙄𝘼𝙇 𝙎𝙐𝙋𝙋𝙊𝙍𝙏 category- is a true pioneer in the 𝙛𝙞𝙜𝙝𝙩 𝙖𝙜𝙖𝙞𝙣𝙨𝙩 𝙖𝙣𝙩𝙞𝙗𝙞𝙤𝙩𝙞𝙘 𝙧𝙚𝙨𝙞𝙨𝙩𝙖𝙣𝙘𝙚 𝙩𝙝𝙧𝙤𝙪𝙜𝙝 𝙥𝙝𝙖𝙜𝙚 𝙩𝙝𝙚𝙧𝙖𝙥𝙮. 🌍🦠 🔬 𝙅𝘼𝙁𝙍𝘼𝙇: 𝙖 𝙬𝙤𝙧𝙡𝙙-𝙡𝙚𝙖𝙙𝙚𝙧 𝙞𝙣 𝙋𝙝𝙖𝙜𝙚 𝙏𝙝𝙚𝙧𝙖𝙥𝙮 𝙏𝙚𝙘𝙝𝙣𝙤𝙡𝙤𝙜𝙮 As a world leader in phage therapy, 𝙅𝘼𝙁𝙍𝘼𝙇 has been at the forefront of innovation since 2011. Phages, which are natural #bacteria killers, offer a groundbreaking solution to overcome #antibiotic resistance—a challenge so severe that the World Health Organization estimates it could cause more deaths by 2050 than cancer. 📈 𝘾𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝙀𝙭𝙘𝙚𝙡𝙡𝙚𝙣𝙘𝙚 Over the years, 𝙅𝘼𝙁𝙍𝘼𝙇 has produced more Clinical Trial material than any other company globally, providing critical treatments to patients and advancing the use of #phage therapy in healthcare. 🏗️ 𝙈𝙖𝙣𝙖𝙜𝙞𝙣𝙜 𝙖 𝘾𝙤𝙢𝙥𝙡𝙚𝙭 𝘽𝙞𝙤𝙩𝙚𝙘𝙝 𝙀𝙘𝙤𝙨𝙮𝙨𝙩𝙚𝙢 Operating in the biotech industry means navigating a complex web of service providers and adhering to stringent #GoodManufacturingPractices (GMP). From raw material supply to equipment maintenance, waste disposal, validation, and testing—every part of the production process requires seamless coordination. 💻 𝙏𝙝𝙚 𝙅𝙖𝙣𝙚𝙩 𝙎𝙤𝙛𝙩𝙬𝙖𝙧𝙚 𝙎𝙤𝙡𝙪𝙩𝙞𝙤𝙣 JAFRAL Biosolutions has developed #Janet, a software solution that has revolutionized how they manage their production system. With the funding, they have built a specialized module that allows them to better manage their service providers, ensuring smoother operations and full compliance with regulatory standards. This support has helped JAFRAL Biosolutions strengthen its position as a global leader in phage therapy and further its mission to combat antibiotic resistance. 🌟 🎉 Congratulations JAFRAL Biosolutions on your achievements! Frenk Smrekar       #phagetherapy #biotech #innovation #financialsupport #GMPcompliance #antibioticresistance #clinicaltrials #healthcare #biomanufacturing #bioproduction #biotech #Slovenia #resilience #impact

The #digitalisation of processes in #biotech companies is a crucial and essential building block for meeting the high #regulatory requirements successfully. We are proud to announce that we enabled JAFRAL Biosolutions to capitalise on the opportunities offered by digitalisation, taking an important step into the future through our funding in BioMan4R2.

With each step following the light.

NalaGenetics sees the future of PGx in collaborative efforts across sectors. CEO Sani foresees greater government involvement in PGx implementation, especially in developing markets. Learn more about Levana Sani and where she’s taking her #innovation next ⬇️ #healthtech #pharmacogenomics #Nalagenetics #precisionmedicine